Table 1 Patient Clinicopathological details
From: MicroRNA-10a is reduced in breast cancer and regulated in part through retinoic acid
| Breast Clinicopathological characteristics | Cancer | Fibroadenoma | Normal |
|---|---|---|---|
| Number of patients | 103 | 35 | 30 |
| Median Patient Age yrs | 56 (35–90) | 44 (17–62) | 46.5 (24–58) |
| Menopausal Status | |||
| Post | 72 | ||
| Pre | 32 | ||
| Histological Subtype | |||
| Invasive Ductal | 78 | ||
| Invasive Lobular | 11 | ||
| Other | 14 | ||
| Intrinsic Subtype | |||
| Luminal A (ER/PR+, HER2/neu-) | 42 | ||
| Luminal B (ER/PR+, HER2/neu+) | 18 | ||
| HER2 Over expressing (ER-, PR-, HER2/neu+) | 16 | ||
| Triple-Negative (ER-, PR-, HER2/neu-) | 16 | ||
| Unknown | 11 | ||
| Tumour Grade | |||
| 1 | 5 | ||
| 2 | 32 | ||
| 3 | 55 | ||
| Tumour size | |||
| 1 | 19 | ||
| 2 | 39 | ||
| 3 | 10 | ||
| UICC Stage | |||
| Stage 1 | 23 | ||
| Stage 2 | 36 | ||
| Stage 3 | 21 | ||
| Stage 4 | 10 |
